5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of live cell enrichment methods for single-cell RNAseq
    Meeting Abstract

    Meskauskaite Urben, B.; Krause, T.; Takizawa, M.; Snopkowski, C.; Masilionis, I.; Remsik, J.; Parisotto, Y.; Brown, C.; Boire, A.; Pe'er, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Precision lineage deconvolution in mixed phenotype acute leukemia using CITE-seq derived hematopoietic stages identifies lineage dynamics associated with treatment response
    Meeting Abstract

    Dilip, D.; Galera, P.; Nemirovsky, D.; Lallo, M.; Menghrajani, K.; Derkach, A.; Levine, R. L.; Koche, R.; Xiao, W.; Glass, J.
    Blood (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin-based regimens for older patients with newly diagnosed classical Hodgkin lymphoma -Real world experience
    Meeting Abstract

    Luttwak, E.; Ganesan, N.; Boardman, A. P.; Caron, P.; David, K. A.; Rivas-Delgado, A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Potent CD8+T-cell proliferation and effector differentiation following subcutaneous (SC) mosunetuzumab administration in patients with untreated, high tumor-burden follicular lymphoma (FL)
    Meeting Abstract

    Falchi, L.; Lin, Y. H.; Melendez, L.; Ghione, P.; Owens, C.; Hamlin, P. A.; Lue, J. K.; Epstein-Peterson, Z. D.; Kumar, A.; Palomba, M. L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Targeted molecular profiling of circulating cell-free DNA in patients with advanced hepatocellular carcinoma
    Journal Article

    Cowzer, D.; White, J. B.; Chou, J. F.; Chen, P. J.; Kim, T. H.; Khalil, D. N.; El Dika, I. H.; Columna, K.; Yaqubie, A.; Light, J. S.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • GBM agile platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib
    Meeting Abstract

    Wen, P.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Application of the GBM-X data platform to estimate treatment effects of the experimental therapies of the randomized phase 2 individualized screening trial of innovative glioblastoma therapies
    Meeting Abstract

    Rahman, R.; Trippa, L.; Fell, G.; Lee, E.; Arrillaga-Romany, I.; Touat, M.; Drappatz, J.; Welch, M.; Galanis, E.; Ahluwalia, M.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Impact of vorasidenib treatment on mutant IDH1 or IDH2 diffuse glioma tumor growth rate: Results from the randomized, double-blind, phase 3 INDIGO study
    Meeting Abstract

    Wen, P.; Mellinghoff, I.; van den Bent, M.; Blumenthal, D.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Mason, W.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A randomized, double-blind phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): Analysis of health-related quality of life, neurocognition and seizures
    Meeting Abstract

    Peters, K.; Mellinghoff, I.; van den Bent, M.; Blumenthal, D.; Touat, M.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Mason, W.; Ducray, F.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • A randomized double-blind phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): Exploratory analysis of variant allele frequency and progression-free survival
    Meeting Abstract

    Cloughesy, T.; Mellinghoff, I.; van den Bent, M.; Blumenthal, D.; Touat, M.; Peters, K.; Clarke, J.; Mendez, J.; Yust-Katz, S.; Mason, W.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save